april, 2018

03apr9:00 am5:30 pmUnderstanding Drug Pricing And ReimbursementWashington, DC9:00 am - 5:30 pm 1201 Maryland Ave, SW, Suite 900, Washington DC 20024


To register for this course purchase your ticket(s) below. There are two ticket prices. BIO Members pay $695 and receive $100 discount. BIO Non-Members pay $795.

Price $695.00$795.00

Order Now


(Tuesday) 9:00 am - 5:30 pm


1201 Maryland Ave, SW, Suite 900, Washington DC 20024

Course Summary

This intense one-day course focuses on the complex relationship between drug manufactures, government policy, insurers, pharmacies, employers, and patients. The course begins by explaining what a drug formulary is, how they differ from one another, and what considerations are accounted for when deciding which drugs to accept onto a formulary. Next, we explore the various constituents concerned with pharmacoepidemiology and how this information is used to inform drug policy. The afternoon begins with pharmacoeconomics and the various methodologies of drug pricing and reimbursement. The course ends with a detailed description of pricing and marketing strategies used by drug manufacturers, with consideration of a drug’s product lifecycle, direct-to-consumer advertising, and discounts to various purchasers such as government and 340b entities. This course is invaluable to those in government, finance, law, insurance, human resources.

All course materials are handed out in the course. There is no pre-work required. Lunch will be provided.

Have questions?

Contact us at 410.377.4429 or info@biotechprimerinc.com


Refund Policy

All courses and products are final sale. No refunds, exchanges or transfers. If you cannot attend your purchased event, you may send someone in your place by notifying Emily Sullivan, Sullivan@BiotechPrimer.com, no later than one week before the start date of the class.


With the purchase of this course, you will automatically be registered for our WEEKLY. You will receive this free educational newsletter, conveying the science behind the headlines, every Thursday. You may unsubscribe with one click at anytime.